Regulation of mammalian muscle type 6-phosphofructo-1-kinase and its implication for the control of the metabolism
β Scribed by Mauro Sola-Penna; Daniel Da Silva; Wagner S. Coelho; Monica M. Marinho-Carvalho; Patricia Zancan
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 207 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1521-6543
- DOI
- 10.1002/iub.393
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Phosphofructokinase (PFK) is a major regulatory glycolytic enzyme and is considered to be the pacemaker of glycolysis. This enzyme presents a puzzling regulatory mechanism that is modulated by a large variety of metabolites, drugs, and intracellular proteins. To date, the mammalian enzyme structure has not yet been resolved. However, it is known that PFK undergoes an intricate oligomerization process, shifting among monomers, dimers, tetramers, and more complex oligomeric structures. The equilibrium between PFK dimers and tetramers is directly correlated with the enzyme regulation, because the dimer exhibits very low catalytic activity, whereas the tetramer is fully active. Several PFK ligands modulate the enzyme, favoring the formation of its dimers or tetramers. The present review integrates recent findings regarding the regulatory aspects of muscle type PFK and discusses their relation to the control of metabolism. Β© IUBMB IUBMB Life, 62(11): 791β796, 2010.
π SIMILAR VOLUMES
## Abstract Human double minute 2 (HDM2) is an oncoprotein overexpressed in many human cancers. HDM2 expression is regulated at multiple levels in cells. Phosphorylation of HDM2 plays an important role in its postβtranslational regulation. In this study, we have shown that the phosphatidylinositol
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.